Mystery of arsenic compound solved
October 14th, 2010 - 4:06 pm ICT by ANIWashington, Oct 14 (ANI): Scientists from Johns Hopkins, Baylor and Stanford have discovered why an arsenic compound, called arsenite, can kill us, and yet function as an effective therapeutic agent against disease and infections.
The researchers have found that arsenite, a common water contaminant in many parts of the world, affects a special protein folding machine in yeast, called TCP, also present in humans.
This information not only opens the doors to developing safer therapeutic alternatives to arsenite-based medicines, but it may allow researchers counter the negative effects of arsenite poisoning.
“By better understanding arsenite, we might be able to protect humans from its hazards in the future,” said Jef D. Boeke, co-author of the study from the Department of Molecular Biology and Genetics and The High Throughput Biology Center at The Johns Hopkins University School of Medicine in Baltimore.
“Arsenite also has beneficial effects, and by focusing on these, we might be able to find safer ways to reap the beneficial effects without the inherent risks involved in using a compound derived from arsenic.”
To make this discovery, scientists used advanced genomic tools and biochemical experiments to show that arsenic disturbs functions of the machinery (chaperonin complex) required for proper folding and maturation of several proteins and protein complexes within yeast cells.
This mechanism of action by arsenic is not unique to yeast, as it has been shown to exist in a range of organisms from bacteria to mammals.
The study has been published in the October 2010 issue of Genetics. (ANI)
- DNA that may contribute to each person's uniqueness identified - Aug 12, 2010
- Fern gene that helps clean soil of arsenic - Jun 11, 2010
- Chinese medicinal plant extract may help develop anticancer drugs - Mar 04, 2011
- Model shows promise to develop therapies for protein folding diseases - Apr 28, 2011
- Small molecules 'could block cell proliferation in cancerous human tumor' - Apr 14, 2011
- New discovery holds promise for liver cancer treatment - Mar 23, 2011
- New compounds may help develop drugs for degenerative nerve diseases - Jan 20, 2010
- Insight into make-up of cells could help in development of new medicines - Jun 22, 2010
- Yeast offers clues to Parkinson's disease - Sep 09, 2010
- 'Survival protein' can help treat neuro-disorders - May 24, 2011
- Drug protects against fatality from extreme heat - Jan 09, 2012
- Molecule that can increase blood flow in vascular disease identified - Mar 11, 2011
- Scientists crack genetic code for form of pancreatic cancer - Jan 21, 2011
- Jet lag pill that slows down body clock to help you 'catch up' 1 step closer - Dec 15, 2010
- Promising candidates for new HIV drugs found - Oct 14, 2009
Tags: arsenic, beneficial effects, biology center, boeke, co author, common water, high throughput, jef, johns hopkins university, johns hopkins university school, johns hopkins university school of medicine, maturation, mechanism of action, molecular biology, protein complexes, school of medicine, therapeutic agent, therapeutic alternatives, water contaminant, yeast cells